0

ALPHAGAN از شرکت ALLERGAN

اطلاعات داروی نمایش داده شده مستقیما از دیتابیس اطلاعات دارویی سازمان غذا و دارو آمریکا (FDA) استخراج می شود و مرتبا به روز رسانی می شود
داروی نمایش داده شده مورد تایید FDA می باشد و اطلاعات ثبت آن در زیر قابل مشاهده است

ALPHAGAN از شرکت ALLERGAN

New Drug Application (NDA): 020490

Company: ALLERGAN

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status TE Code RLD RS
ALPHAGAN BRIMONIDINE TARTRATE 0.5% SOLUTION/DROPS;OPHTHALMIC Discontinued

None

No No
Original Approvals or Tentative Approvals
Action Date Submission Action Type Submission Classification Review Priority; Orphan Status Letters, Reviews, Labels, Patient Package Insert Notes Url
03/13/1997 ORIG-1 Approval

Type 3 – New Dosage Form

STANDARD

Label is not available on this site.

Supplements
Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels, Patient Package Insert Note Url
03/23/2016 SUPPL-8 Labeling-Package Insert

Label (PDF)

Letter (PDF)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/020490s008lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2016/020490Orig1s008ltr.pdf

12/20/2001 SUPPL-7 Efficacy-New Patient Population

Label (PDF)

Letter (PDF)

Review

https://www.accessdata.fda.gov/drugsatfda_docs/label/2001/21262s6lbl.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/nda/2001/20-490S007_Brimonidine%20Tartrate%20Ophthalmic_Approv.pdf

https://www.accessdata.fda.gov/drugsatfda_docs/nda/2001/20-490s007_Alphagan.cfm

04/09/2001 SUPPL-6 Manufacturing (CMC)-Control

Label is not available on this site.

05/26/2000 SUPPL-5 Manufacturing (CMC)-Control

Label is not available on this site.

08/26/1999 SUPPL-4 Manufacturing (CMC)-Control

Label is not available on this site.

05/20/1998 SUPPL-3 Manufacturing (CMC)

Label is not available on this site.

02/25/1998 SUPPL-2 Manufacturing (CMC)-Control

Label is not available on this site.

01/15/1998 SUPPL-1 Manufacturing (CMC)-Control

Label is not available on this site.

Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels,
Patient Package Insert
Note Url
03/23/2016 SUPPL-8

Labeling-Package Insert

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/020490s008lbl.pdf
12/20/2001 SUPPL-7

Efficacy-New Patient Population

Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2001/21262s6lbl.pdf
برچسب‌ها:

نظرات کاربران

خروج از نسخه موبایل